Estimated PAFs ranged from 9.9% (95%CI, -11.4%, 27.2%) for ER- breast cancer to 31.2% (95%CI, 11.0%, 46.9%) for ER + PR- breast cancer; the PAFs are presented in Table 3. This evidence concerns the gene PGR and breast carcinoma.